| [February 13, 2018] |
 |
MedX Receives Corporate Citizenship Award from the Melanoma Network of Canada
MedX Health Corp. ("MedX") (TSX-V: MDX) announced today that it received
a Corporate Citizenship Award from the Melanoma Network of Canada
("MNC") for MedX's work in raising melanoma awareness.
Alexa Cain, Executive Director of MNC, and Don Fernald, a Director on
MNC's Board, presented a plaque and a glass sculpture, designed by
acclaimed Canadian artist Paull Rodrigue, to the MedX team at MedX's
offices in Mississauga.
"The support from MedX has been truly amazing and inspiring. MedX has
helped champion the work we do at MNC, and is our partner in providing
information about early skin cancer detection, providing skin screening
at our charity events," Ms. Cain said.
Accepting the award on behalf of MedX, President and CEO Rob von der
Porten said, "It is an honor for MedX to be acknowledged by the MNC. We
believe in the great work they do in helping individuals and their
families afflicted by melanoma and other skin cancers. We also believe
that MedX's pain-free SIAscopy technology is a game-changer for the
early detection of skin cancers. Our goal is to significantly cut skin
cancer mortality rates globally."
About MedX
MedX, headquartered in Mississauga, Ontario, is a
leading medical device company focused on skin cancer with its SIAscopy
technology. This technology is imbedded in its products SIAMETRICS™,
SIMSYS™, nd MoleMate™, which MedX manufactures in its ISO 13485
certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include
hand-held devices that use patented technology utilizing light and its
remittance to view up to 2 mm beneath suspicious moles and lesions in a
pain free, non-invasive manner, with its software then creating
real-time images for physicians and dermatologists to evaluate all types
of moles or lesions within seconds. The devices are sold to physicians
and clinics, as well as being deployed in pharmacies and remote clinics
from where the images are sent to dermatologists who perform a
diagnosis. These products are Health Canada, FDA (US), ARTG and CE
approved for use in Canada, the US, Australia, the European Union and
Turkey. SIAMETRICS™ is a unique product used in a specialized market for
research into the clinical effectiveness of medical treatments of
certain skin conditions. MedX also designs, manufactures and distributes
quality laser and light therapy technologies for use in numerous medical
settings, approved in major jurisdictions, to provide drug free and
non-invasive treatment of tissue damage and pain. For more information
and a complete profile of MedX and its products visit www.medxhealth.com.
About Melanoma Network of Canada
The Melanoma Network of
Canada (MNC) provides support services, information and programs for
individuals whose lives have been changed by melanoma. MNC provides the
leading national voice for melanoma patients in Canada for early
detection and improved treatment access and works diligently to prevent
more Canadians from developing melanoma through public awareness and
youth and adult education on sun safety. For more information, please
visit www.melanomanetwork.ca.
Charitable Registration number: 854913050RR0001
View source version on businesswire.com: http://www.businesswire.com/news/home/20180213006619/en/
[ Back To TMCnet.com's Homepage ]
|
